AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 120 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $37,000 | +270.0% | 1,850 | 0.0% | 0.00% | – |
| Q3 2019 | $10,000 | -16.7% | 1,850 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | -20.0% | 1,850 | -19.6% | 0.00% | – |
| Q1 2019 | $15,000 | 0.0% | 2,300 | +4.5% | 0.00% | – |
| Q4 2018 | $15,000 | +200.0% | 2,200 | +214.3% | 0.00% | – |
| Q3 2018 | $5,000 | +25.0% | 700 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | +33.3% | 700 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | -25.0% | 700 | 0.0% | 0.00% | – |
| Q3 2017 | $4,000 | -69.2% | 700 | -68.2% | 0.00% | – |
| Q2 2017 | $13,000 | -38.1% | 2,200 | -24.1% | 0.00% | – |
| Q1 2017 | $21,000 | +950.0% | 2,900 | +190.0% | 0.00% | – |
| Q4 2016 | $2,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |